title: [Sirolimus-eluting stent displaced fracture: case report and review of the literature].
abstract: Drug-eluting stents have greatly reduced the risk of in-stent restenosis compared to bare metal stents by inhibiting neointimal growth. However, they may carry some long-term risks, especially the risk of late stent thrombosis. Recently, several cases of drug-eluting stent fracture have been also reported. The mechanisms, the diagnosis, the clinical implications and the management of this new complication are not well-known. We report the observation of a new case of displaced, sirolimus drug-eluting stent fracture. To our knowledge, this is the first reported case in France.
authors.affiliation: Service de cardiologie, centre hospitalier de Gonesse, 25 rue Bernard-Février, Gonesse, France. helmibensalem@yahoo.fr
authors.forename: H
authors.initials: H
authors.lastname: Ben Salem
authors.forename: M
authors.initials: M
authors.lastname: Kamoun
authors.forename: H
authors.initials: H
authors.lastname: Khaldi
authors.forename: K
authors.initials: K
authors.lastname: Ghannem
authors.forename: S
authors.initials: S
authors.lastname: Majadla
authors.forename: M
authors.initials: M
authors.lastname: Ghannem
authors.forename: S
authors.initials: S
authors.lastname: Godard
mesh_terms: D000328:Adult; D054855:Drug-Eluting Stents; D006801:Humans; D008297:Male; D011475:Prosthesis Failure; D020123:Sirolimus / Q000008:administration & dosage*
chemical_list: D020123:Sirolimus